Pengcheng Sun — Harbin Medical University

Area of research

Molecular Biology · Cancer Research

Research interest

Research focused on Cancer research and Viability assay, with related work in Protein kinase B, PI3K/AKT/mTOR pathway, Clear cell renal cell carcinoma. Notable publications include 'MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways', 'miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion', and 'MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells'.

Recent publications

LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer

Evidence-based Complementary and Alternative Medicine 2021cited by 11position: lastdoi

miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion

Oncotarget 2017cited by 35position: middledoi

MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells

Bioscience Reports 2017cited by 29position: firstdoi

Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways

Cellular Physiology and Biochemistry 2017cited by 9position: firstdoi

MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways

International Journal of Oncology 2016cited by 43position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Molecular Biology · Cancer Research →